Treatment Information

Back

Mesothelioma treatment details. Chemotherapy.

University of Chicago Medical Center, Chicago, Illinois, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Chicago, Illinois
Treatments:ChemotherapyHospital:University of Chicago Medical Center
Drugs:Journal:Link
Date:Nov 1999

Description:

Patients: This Phase II study involved 20 patients with malignant mesothelioma who could not be treated by surgery or radiation alone.

Treatment: The treatment consisted of administration of the drug edatrexate with leucovorin.

Toxicity: Grade 3-4 toxicities included hematologic, infection, muscositis, esophagitis/dysphagia, dermatologic, anorexia, malaise/fatigue, cardiac, pulmonary, hepatic, and neurologic.

Results: The median survival duration was 6.6 months.





Back